W Joost Wiersinga

InstitutionUniversity of Amsterdam
AddressThe
Netherlands
vCardDownload vCard
    Publication Timeline
    COVID-19 publications
    Bar chart showing 18 Covid-19 publications, with a maximum of 3 publications in January 2021
    All Publications
    Bar chart showing 119 publications over 20 distinct years, with a maximum of 17 publications in 2017
    These graphs show COVID-19 publications by month since August 2019 and all publications written by authors of COVID-19 publications over the past 30 years.

    To see the data from both graphs as text, click here.
    Publication Field Summary
    This graph shows the number and percent of publications by field. Fields are based on how the National Library of Medicine (NLM) classifies the publications' journals and might not represent the specific topics of the publications. Note that an individual publication can be assigned to more than one field. As a result, the publication counts in this graph might add up to more than the number of publications the person has written. To see the data as text, click here.
    Publication List
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications.
    Sort By:     Newest   |   Oldest   |   Most Cited   |   Most Discussed
    PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Schuurman AR, Reijnders TDY, Saris A, Ramirez Moral I, Schinkel M, de Brabander J, van Linge C, Vermeulen L, Scicluna BP, Wiersinga WJ, Vieira Braga FA, van der Poll T. Integrated single-cell analysis unveils diverging immune features of COVID-19, influenza, and other community-acquired pneumonia. Elife. 2021 08 23; 10. PMID: 34424199.
      Citations:    Fields:    Translation:HumansCells
    2. Citations: 2     Fields:    Translation:Humans
    3. Sikkens JJ, Buis DTP, Peters EJG, Dekker M, Schinkel M, Reijnders TDY, Schuurman AR, de Brabander J, Lavell AHA, Maas JJ, Koopsen J, Han AX, Russell CA, Schinkel J, Jonges M, Matamoros S, Jurriaans S, van Mansfeld R, Wiersinga WJ, Smulders YM, de Jong MD, Bomers MK. Serologic Surveillance and Phylogenetic Analysis of SARS-CoV-2 Infection Among Hospital Health Care Workers. JAMA Netw Open. 2021 07 01; 4(7):e2118554. PMID: 34319354.
      Citations: 6     Fields:    Translation:HumansPHPublic Health
    4. Wiersinga WJ, van der Valk M. Severe coronavirus disease 2019 in a patient with HIV-2 infection. AIDS. 2021 06 01; 35(7):1151-1152. PMID: 33946091.
      Citations:    Fields:    Translation:HumansCells
    5. de Bruin S, Bos LD, van Roon MA, Tuip-de Boer AM, Schuurman AR, Koel-Simmelinck MJA, Bogaard HJ, Tuinman PR, van Agtmael MA, Hamann J, Teunissen CE, Wiersinga WJ, Koos Zwinderman AH, Brouwer MC, van de Beek D, Vlaar APJ. Clinical features and prognostic factors in Covid-19: A prospective cohort study. EBioMedicine. 2021 May; 67:103378. PMID: 34000622.
      Citations: 6     Fields:    Translation:Humans
    6. Osuchowski MF, Winkler MS, Skirecki T, Cajander S, Shankar-Hari M, Lachmann G, Monneret G, Venet F, Bauer M, Brunkhorst FM, Weis S, Garcia-Salido A, Kox M, Cavaillon JM, Uhle F, Weigand MA, Flohé SB, Wiersinga WJ, Almansa R, de la Fuente A, Martin-Loeches I, Meisel C, Spinetti T, Schefold JC, Cilloniz C, Torres A, Giamarellos-Bourboulis EJ, Ferrer R, Girardis M, Cossarizza A, Netea MG, van der Poll T, Bermejo-Martín JF, Rubio I. The COVID-19 puzzle: deciphering pathophysiology and phenotypes of a new disease entity. Lancet Respir Med. 2021 06; 9(6):622-642. PMID: 33965003.
      Citations: 37     Fields:    Translation:Humans
    7. Schinkel M, Appelman B, Butler J, Schuurman A, Wiersinga WJ. Association of clinical sub-phenotypes and clinical deterioration in COVID-19: further cluster analyses. Intensive Care Med. 2021 04; 47(4):482-484. PMID: 33604760.
      Citations: 1     Fields:    Translation:Humans
    8. Citations:    Fields:    Translation:Humans
    9. Léopold V, Pereverzeva L, Schuurman AR, Reijnders TDY, Saris A, de Brabander J, van Linge CCA, Douma RA, Chouchane O, Nieuwland R, Wiersinga WJ, van 't Veer C, van der Poll T. Platelets are Hyperactivated but Show Reduced Glycoprotein VI Reactivity in COVID-19 Patients. Thromb Haemost. 2021 09; 121(9):1258-1262. PMID: 33412595.
      Citations: 7     Fields:    Translation:HumansCells
    10. Schinkel M, Virk HS, Nanayakkara PWB, van der Poll T, Wiersinga WJ. What Sepsis Researchers Can Learn from COVID-19. Am J Respir Crit Care Med. 2021 01 01; 203(1):125-127. PMID: 33125253.
      Citations: 1     Fields:    Translation:HumansPHPublic Health
    11. Wiersinga WJ, de Bree GJ. [Covid-19 reinfections: what is the clinical relevance?] Ned Tijdschr Geneeskd. 2020 12 03; 164. PMID: 33332056.
      Citations: 1     Fields:    Translation:HumansPHPublic Health
    12. Prescott HC, Sussman JB, Wiersinga WJ. Postcritical illness vulnerability. Curr Opin Crit Care. 2020 10; 26(5):500-507. PMID: 32773618.
      Citations: 1     Fields:    Translation:HumansCellsPHPublic Health
    13. Sieswerda E, de Boer MGJ, Bonten MMJ, Boersma WG, Jonkers RE, Aleva RM, Kullberg BJ, Schouten JA, van de Garde EMW, Verheij TJ, van der Eerden MM, Prins JM, Wiersinga WJ. Recommendations for antibacterial therapy in adults with COVID-19 - an evidence based guideline. Clin Microbiol Infect. 2021 Jan; 27(1):61-66. PMID: 33010444.
      Citations: 29     Fields:    Translation:Humans
    14. Vlaar APJ, de Bruin S, Busch M, Timmermans SAMEG, van Zeggeren IE, Koning R, Ter Horst L, Bulle EB, van Baarle FEHP, van de Poll MCG, Kemper EM, van der Horst ICC, Schultz MJ, Horn J, Paulus F, Bos LD, Wiersinga WJ, Witzenrath M, Rueckinger S, Pilz K, Brouwer MC, Guo RF, Heunks L, van Paassen P, Riedemann NC, van de Beek D. Anti-C5a antibody IFX-1 (vilobelimab) treatment versus best supportive care for patients with severe COVID-19 (PANAMO): an exploratory, open-label, phase 2 randomised controlled trial. Lancet Rheumatol. 2020 Dec; 2(12):e764-e773. PMID: 33015643.
      Citations: 45     
    15. Wiersinga WJ, Rhodes A, Cheng AC, Peacock SJ, Prescott HC. Pathophysiology, Transmission, Diagnosis, and Treatment of Coronavirus Disease 2019 (COVID-19): A Review. JAMA. 2020 Aug 25; 324(8):782-793. PMID: 32648899.
      Citations: 1019     Fields:    Translation:HumansCellsPHPublic Health
    16. Wiersinga WJ, Prescott HC. What Is COVID-19? JAMA. 2020 08 25; 324(8):816. PMID: 32648917.
      Citations: 8     Fields:    Translation:HumansCellsPHPublic Health
    17. Citations: 372     Fields:    Translation:HumansCellsPHPublic Health
    18. Wiersinga WJ. [Clinical Characteristics of Coronavirus Disease 2019 in the Netherlands]. Ned Tijdschr Geneeskd. 2020 05 13; 164. PMID: 32406637.
      Citations:    Fields:    Translation:HumansCellsPHPublic Health
    Wiersinga's Networks
    Click the
    Explore
    buttons for more information and interactive visualizations!
    Concepts (232)
    Explore
    _
    Co-Authors (221)
    Explore
    _
    Similar People (60)
    Explore
    _